Add BrightSurf on Google Email

Science News for December 28, 2016


Fenofibrate may reduce heart disease risk in some patients with type 2 diabetes

A new study found that fenofibrate therapy may be beneficial in reducing cardiovascular events in patients with type 2 diabetes who take statins but still have high triglyceride levels and low HDL cholesterol levels. The study suggests a potential benefit of combining fenofibrate with statin treatment for this specific patient population.

Magnetic stem cells for gene engineering

Scientists at Tomsk Polytechnic University have developed magnetic stem cells that can target cancer cells with precision and deliver medication directly to the tumor site. The technology uses patient's own magnet-controlled cells, which are not rejected by the immune system and cause less harm.

SourceTomsk Polytechnic University·JournalAdvanced Healthcare Materials·DateDec 28, 2016

Predicting and preventing violence against criminal justice officials

A scoring system, known as Dr. Logan's triage tool, can help law enforcement identify high-risk individuals who may pose a threat to criminal justice officials. The tool assesses danger-related factors such as rule breaking, violence at a young age, and substance abuse to predict attacks against police, judges, and other officials.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalViolence and Gender·DateDec 28, 2016